Challenge Programme 2023 – RNA- and Oligonucleotide-based Therapeutics (Denmark)
The Challenge Programme 2023 – RNA- and Oligonucleotide-based Therapeutics from the Novo Nordisk Fonden (NNF) supports research teams working on basic science that facilitate development of RNA and oligonucleotide-based therapeutics within common clinical conditions, primarily cardiometabolic diseases, efficiently targeting the relevant tissue, cell types and subcellular localisation. The project lead must be at least 75% affiliated with a Danish university, research institution or other non-profit organization. The programme provides between 30-60 million DKK over 6 years. Applications close on October 26, 2022.
Challenge: SDG3 - Good Health and Well-being
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.